The Deborah Heart and Lung Center is located in Browns Mills, Burlington County, New Jersey, United States. It is the only hospital in the Delaware Valley region that focuses exclusively on cardiac, vascular, and lung disease. Deborah Heart and Lung Center has 89 beds with a full-service ambulatory care center.

There are 89 beds in Deborah Heart and Lung Center.

During the past decade, Deborah Heart and Lung Center conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 31 clinical trials were completed, i.e. on average, 96.9% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 19 clinical trials were completed. i.e. 237.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Deborah Heart and Lung Center" #1 sponsor was "Abbott Medical Devices" with 19 trials, followed by "Boston Scientific Corporation" with 10 trials sponsored, "Avinger, Inc." with 3 trials sponsored, "Spectranetics Corporation" with 3 trials sponsored and "Biotronik, Inc." with 3 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Deborah Heart and Lung Center" #1 collaborator was "Massachusetts General Hospital" with 5 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "ClinLogix. LLC" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 40 trials.

According to Clinical.Site data, the most researched conditions in "Deborah Heart and Lung Center" are "Heart Failure" (15 trials), "Peripheral Arterial Disease" (10 trials), "Coronary Artery Disease" (8 trials), "Cardiovascular Diseases" (4 trials) and "Bradycardia" (3 trials). Many other conditions were trialed in "Deborah Heart and Lung Center" in a lesser frequency.

Most popular intervention types in "Deborah Heart and Lung Center" are "Device" (56 trials), "Drug" (8 trials), "Procedure" (5 trials), "Diagnostic Test" (3 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "COBRA PzF" (2 trials), "Lutonix Drug Coated Balloon" (2 trials), "MPP" (2 trials), "0.1% TR 987" (1 trials) and "3 months of dual antiplatelet therapy (DAPT)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Deborah Heart and Lung Center" are 66 trials for "All" genders.

Currently, there are NaN active trials in "Deborah Heart and Lung Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Deborah Heart and Lung Center, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Deborah Heart and Lung Center, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 42 trials that are defined as “Not Applicable".